Get the Latest Biopharma and Pharma Manufacturing News

aem-GridColumn aem-GridColumn--default--12

Pharma manufacturing bioreactor

Biopharmaceutical process development demands early, high-stakes decisions across raw material selection, manufacturing process design, and regulatory strategy — decisions that are costly to revise later. The Merck Process Solutions newsletter delivers expert guidance to help you navigate those decisions with confidence.
Each issue covers:
<ul>
<li>Best practices for process development and manufacturing across viral vector therapies, mRNA therapeutics, monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and small molecules</li>
<li>New raw materials, analytical tools, and bioprocessing services designed to improve process economics and reduce time to market</li>
<li>Practical strategies for mitigating production risks and scaling from development to commercial manufacturing</li>
</ul>
Subscribe to stay ahead of evolving industry standards and get actionable insights from Merck's pharma and biopharma manufacturing experts.

aem-GridColumn aem-GridColumn--default--9 aem-GridColumn--offset--default--0 aem-GridColumn--default--none

Register for our pharma manufacturing newsletter to stay up to date on process development and manufacturing challenges for viral vector therapies, mRNA, mAbs, ADCs, and small molecules.